SCHEMBL22828186

SCHEMBL22828186

CNCC(C)(N)CC(C)(C)C(N)=O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15726863 0.80
Hydrochloric Acid SCHEMBL16825035 0.78 KDM4E (0.30) GRM4
SCHEMBL14457220 0.76 MEN1 (0.30)
SCHEMBL8273528 0.72 GRM4 (0.32) GRM4
SCHEMBL21415349 0.71
SCHEMBL16057383 0.70
SCHEMBL6896428 0.69 LMNA (0.35)
SCHEMBL22790615 0.68
SCHEMBL4561427 0.67
SCHEMBL12463880 0.67 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257235-A1 1-(4-(AMINOMETHYL)BENZYL)-2-BUTYL-2H-PYRAZOLO[3,4-C]QUINOLIN-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS TOLL-LIKE RECEPTOR (TLR) 7/8 AGONISTS, AS WELL AS ANTIBODY DRUG CONJUGATES THEREOF FOR USE IN CANCER THERAPY AND DIAGNOSIS SUTRO BIOPHARMA, INC. (US) 2020-12-24 WO disclosed